fda approved semaglutide Is GLP-1 Safe for Weight Loss? FDA-Approved Oral Semaglutide Pill |

A: According to clinical trial data and FDA review: Clinical trials have studied GLP-1 medications for chronic weight management for up to 2-3 years, demonstrating acceptable safety profiles for most individuals during this timeframe

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Avoid heat, light, and freezing: Exposure to high temperatures, sunlight, or freezing can degrade the medication and reduce its effectiveness

They do show that weight maintenance should be discussed early, before a patient reaches a goal weight or stops treatment abruptly

Literature and video were very helpful

Patients switching from semaglutide to tirzepatide often experience renewed appetite suppression, improved energy stability, and metabolic flexibility within 46 weeks